DTIC ADA502889: Development of Novel Bifunctional Compounds pdf

DTIC ADA502889: Development of Novel Bifunctional Compounds

More Book Details

Description of the Book:

We have designed and synthesized a novel compound (11?) that efficiently triggers apoptosis in prostate cancer cells such as LNCaP. This bifunctional compound was designed to form DNA adducts that are camouflaged by the androgen receptor making them less readily repaired in AR+ prostate cancer cells. The aims of our studies are to investigate the mechanisms by which 11? is able to trigger apoptosis in target cells. Methods have been developed that permit us to determine the fates of 11?-DNA adducts in treated cells in culture as well as in tumors growing in animal models. Another objective is to identify the signaling events that lead from DNA adducts to activation of the apoptotic program. Finally we have obtained encouraging results from animal experiments that indicate that molecules such as 11? may have clinical potential for the treatment of human tumors

• Creator/s: Defense Technical Information Center
• Date: 3/1/2009
• Year: 2009
• Book Topics/Themes: DTIC Archive, , MASSACHUSETTS INST OF TECH CAMBRIDGE, *CELLS(BIOLOGY), *PROSTATE CANCER, DEOXYRIBONUCLEIC ACIDS, MEDICAL SERVICES, APOPTOSIS, CHEMOTHERAPY, STEROIDS, NEOPLASMS, CLINICAL MEDICINE

An excerpt captured from the PDF book